Shares of Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 82,587 shares traded hands during mid-day trading, an increase of 51% from the previous session’s volume of 54,707 shares.The stock last traded at $16.5370 and had previously closed at $16.69.
Analyst Upgrades and Downgrades
Separately, Citigroup downgraded Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research report on Monday, January 26th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $30.15.
Get Our Latest Report on Sonic Healthcare
Sonic Healthcare Stock Performance
Sonic Healthcare Company Profile
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Featured Articles
- Five stocks we like better than Sonic Healthcare
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
